Skip to Content

TARO LVT 250 (Levetiracetam 250 mg)

Pill imprint TARO LVT 250 has been identified as Levetiracetam 250 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; new daily persistent headache; bipolar disorder; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.